Wu Qinghua, Shi Hui-rong, Liu Ning, Lu Ning, Jiang Miao, Zhao Zhen-hua, Kong Xiang-dong
Center of Prenatal Diagnosis, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2012 Aug;29(4):377-81. doi: 10.3760/cma.j.issn.1003-9406.2012.04.001.
To evaluate the feasibility of genetic analysis of tyrosinase gene (TYR) in oculocutaneous albinism type I (OCA1). Mutation analysis and prenatal genetic diagnosis of TYR gene for seven pedigrees with OCA1 were performed.
PCR was used to amplify the exons, exon-intron boundaries and promoter of the TYR gene in the probands and/or their parents. The products were further analyzed by direct sequencing. Prenatal genetic diagnoses were performed by chorionic villus sampling after the genotypes of the probands or their parents were determined.
Compound heterozygous mutations were detected in all pedigrees, which included 9 mutations, namely R76Q, c.232insGGG, R116X, R278X, R299H, c.929-930insC, IVS2-11delTT, Q399X and W400L. Among these, R76Q and Q399X were identified for the first time. Seven families have requested prenatal diagnoses. One fetus was detected with double mutations of TYR gene, and the parents have decided to have therapeutic abortion. Two fetuses did not carry the mutations identified in the probands, whilst other four fetuses were carriers of heterozygous mutations. Six families decided to carry on with the pregnancies. And the neonates did not show any symptoms of OCA after birth.
Direct sequencing of the TYR gene is helpful for genetic counseling, prenatal diagnosis and carriers screening of OCA1.
评估对Ⅰ型眼皮肤白化病(OCA1)患者进行酪氨酸酶基因(TYR)遗传分析的可行性。对7个OCA1家系进行了TYR基因的突变分析及产前基因诊断。
采用聚合酶链反应(PCR)扩增先证者及其父母的TYR基因外显子、外显子-内含子边界及启动子。产物进一步通过直接测序进行分析。在确定先证者或其父母的基因型后,通过绒毛取样进行产前基因诊断。
所有家系均检测到复合杂合突变,共9种突变,即R76Q、c.232insGGG、R116X、R278X、R299H、c.929 - 930insC、IVS2 - 11delTT、Q399X和W400L。其中,R76Q和Q399X为首次发现。7个家庭要求进行产前诊断。1例胎儿检测到TYR基因双突变,其父母决定引产。2例胎儿未携带先证者中鉴定出的突变,另外4例胎儿为杂合突变携带者。6个家庭决定继续妊娠。新生儿出生后未表现出任何OCA症状。
TYR基因直接测序有助于OCA1的遗传咨询、产前诊断及携带者筛查。